Home
>
National Drug Code (NDC)
>
Evista
Evista - 0002-4165-02 - (Raloxifene hydrochloride)
Drug Information of Evista
| Product NDC: | 0002-4165 |
| Proprietary Name: | Evista |
| Non Proprietary Name: | Raloxifene hydrochloride |
| Active Ingredient(s): | 60 mg/1 & nbsp; Raloxifene hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Evista
| Product NDC: | 0002-4165 |
| Labeler Name: | Eli Lilly and Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020815 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980106 |
Package Information of Evista
| Package NDC: | 0002-4165-02 |
| Package Description: | 100 TABLET in 1 BOTTLE (0002-4165-02) |
NDC Information of Evista
| NDC Code | 0002-4165-02 |
| Proprietary Name | Evista |
| Package Description | 100 TABLET in 1 BOTTLE (0002-4165-02) |
| Product NDC | 0002-4165 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Raloxifene hydrochloride |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19980106 |
| Marketing Category Name | NDA |
| Labeler Name | Eli Lilly and Company |
| Substance Name | RALOXIFENE HYDROCHLORIDE |
| Strength Number | 60 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Estrogen Agonist/Antagonist [EPC],Selective Estrogen Receptor Modulators [MoA] |
